Download in electronic PDF format for $25

Kalchem International - Chemicals and Compounding Supplies

Search the Complete Journal Archives

U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies

Author(s):  Yoch Doug

Issue:  Mar/Apr 2017 - Volume 21, Number 2
View All Articles in Issue

Abstract:  The reasons for which pharmaceutical compounding is the focus of intense state and federal scrutiny are now well known. Compounders are faced with an ever-increasing need to prove, by objective standards, the safety, purity, and potency of the formulations they dispense. They must also demonstrate their compliance with regulations often based on current good compounding practices designed for the pharmaceutical industry. In the U.S. today, rigorous unannounced state and federal inspections of compounding facilities are occurring more and more frequently. To achieve a successful outcome, communicating clearly and effectively with inspectors and having ready access to the information they request are as critical as proving compliance. This article describes the author’s experience with an unannounced United States Food and Drug Administration inspection of his 503A compounding facility and his response to the findings. Readers will learn what to expect during such an inspection, how to prepare for that event, and how to achieve an excellent outcome. Those who would like more information about any of the topics presented are invited to contact the author at the address provided at the close of this article.

Related Keywords: Doug Yoch, PharmD, U.S. Food and Drug Administration, FDA, pharmacy inspection, 503A sterile compounding pharmacies, pharmacy standards, pharmacy regulation, inspectors, documentation, recordkeeping, standard operating procedure, gap analysis

Related Categories: LEGAL, STERILE PREPARATIONS, QUALITY CONTROL

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies Yoch Doug Mar/Apr 2017 95-102 Buy
Certification, Accreditation, and Credentialing for 503A Compounding Pharmacies Pritchett Jon, McCrory Gary, Kraemer Cheri, Jensen Brenda, Allen Loyd V Jr Jan/Feb 2018 7-16 Buy
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Allen Loyd V Jr Jul/Aug 2016 351 View Sample
PreScription: Compounding Pharmacy Issues for 2017 Allen Loyd V Jr Jan/Feb 2017 4 Buy
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Allen Loyd V Jr Sep/Oct 2017 356 Buy
Standard Operating Procedure: U.S. Food and Drug Administration Inspection--Releasing a Sample to the U.S. Food and Drug Administration Kupiec Tom, Kemp Jesse Jul/Aug 2007 326-327 Buy
Applying Quality of Design Concepts to Pharmacy Compounding Timko Robert J Nov/Dec 2015 453-463 Buy
Obtaining Accreditation by the Pharmacy Compounding Accreditation Board, Part 2: Developing Essential Standard Operating Procedures Cabaleiro Joe Sep/Oct 2007 397-398 Buy
Compounding Pharmacies: Before and After an Inspection Kulkarni Darshan, Ricketts Samantha Sep/Oct 2013 358-362 Buy
Regulatory and Operational Issues of Founding a Compounding Pharmacy Smith Lisa K Nov/Dec 2002 434-437 Buy